{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:13Z","timestamp":1789609213996,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.rdc.2014.09.008","type":"journal-article","created":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T22:59:15Z","timestamp":1416437955000},"page":"93-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cold Hard Facts of Cryoglobulinemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Daniela","family":"Ghetie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Mehraban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailin H.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.rdc.2014.09.008_bib2","first-page":"395","article-title":"Cryoglobulins: an important but neglected clinical test","volume":"36","author":"Shihabi","year":"2006","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clim.2008.07.012","article-title":"Establishment of reference values for immunoglobulins in the cryoprecipitate","volume":"129","author":"Vermeersch","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2014.09.008_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/asheducation-2005.1.368","article-title":"Cryoglobulinemia","author":"Morra","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"21","key":"10.1016\/j.rdc.2014.09.008_bib6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A\u00a0role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-117-7-573","article-title":"Hepatitis C virus infection in patients with essential mixed cryoglobulinemia","volume":"117","author":"Misiani","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-87-3-287","article-title":"Liver involvement in the syndrome of mixed cryoglobulinemia","volume":"87","author":"Levo","year":"1977","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.rdc.2014.09.008_bib9","first-page":"209","article-title":"Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC)","volume":"7","author":"Galli","year":"1992","journal-title":"Ann Ital Med Int"},{"issue":"9","key":"10.1016\/j.rdc.2014.09.008_bib10","first-page":"2005","article-title":"Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients","volume":"30","author":"Bonnet","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib11","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias","volume":"88","author":"Monti","year":"1995","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.rdc.2014.09.008_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2893.2000.00204.x","article-title":"Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C","volume":"7","author":"Cicardi","year":"2000","journal-title":"J\u00a0Viral Hepat"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib14","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3899\/jrheum.080874","article-title":"Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)","volume":"36","author":"Ramos-Casals","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","article-title":"Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies","volume":"46","author":"Vassilopoulos","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/sarh.2001.20265","article-title":"Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients","volume":"30","author":"Garcia-Carrasco","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0049-0172(98)80037-1","article-title":"Cryoglobulinemia in primary Sjogren's syndrome: prevalence and clinical characteristics in a series of 115 patients","volume":"28","author":"Ramos-Casals","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2003-44555","article-title":"Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations","volume":"29","author":"Della Rossa","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib20","first-page":"305","article-title":"Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia","volume":"21","author":"Sansonno","year":"1995","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.510250529","article-title":"Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis","volume":"25","author":"Sansonno","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2893.2005.00675.x","article-title":"Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia","volume":"13","author":"Ferri","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"issue":"5390","key":"10.1016\/j.rdc.2014.09.008_bib23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"51","key":"10.1016\/j.rdc.2014.09.008_bib24","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.rdc.2014.09.008_bib26","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","article-title":"CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis","volume":"103","author":"Boyer","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.rdc.2014.09.008_bib27","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.23759","article-title":"Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2014.09.008_bib28","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","article-title":"Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis","volume":"111","author":"Saadoun","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib29","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/hep.25821","article-title":"B\u00a0cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naive B cell apoptosis","volume":"56","author":"Holz","year":"2012","journal-title":"Hepatology"},{"issue":"298","key":"10.1016\/j.rdc.2014.09.008_bib30","first-page":"101","article-title":"Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients","volume":"82","author":"Frankel","year":"1992","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.rdc.2014.09.008_bib31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0002-9343(66)90199-9","article-title":"Cryoglobulinemia\u2013a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"issue":"1 Pt 1","key":"10.1016\/j.rdc.2014.09.008_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0190-9622(91)70168-2","article-title":"Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients","volume":"25","author":"Cohen","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0049-0172(81)80004-2","article-title":"Articular manifestations of essential cryoglobulinemia","volume":"10","author":"Weinberger","year":"1981","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.rdc.2014.09.008_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MD.0b013e3181c1750f","article-title":"Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection","volume":"88","author":"Matignon","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3899\/jrheum.090790","article-title":"Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy","volume":"37","author":"Landau","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.09.008_bib39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1988.00520350048015","article-title":"Peripheral neuropathy in essential mixed cryoglobulinemia","volume":"45","author":"Garcia-Bragado","year":"1988","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jnnp.55.2.116","article-title":"Peripheral neuropathy in essential mixed cryoglobulinaemia","volume":"55","author":"Gemignani","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.rdc.2014.09.008_bib41","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib42","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/0002-9343(79)91112-4","article-title":"Lung involvement in essential mixed cryoglobulinemia","volume":"66","author":"Bombardieri","year":"1979","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02030345","article-title":"Lung function in essential mixed cryoglobulinemia: a short-term follow-up","volume":"8","author":"Viegi","year":"1989","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib45","first-page":"616","article-title":"Alveolar hemorrhage in cryoglobulinemia\u2013an indicator of poor prognosis","volume":"23","author":"Amital","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"9813","key":"10.1016\/j.rdc.2014.09.008_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(85)90540-6","article-title":"Evaluation of hyperviscosity in monoclonal gammopathies","volume":"79","author":"Crawford","year":"1985","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.rdc.2014.09.008_bib48","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1136\/gut.2010.218123","article-title":"Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients","volume":"59","author":"Terrier","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2011.150755","article-title":"Preliminary classification criteria for the cryoglobulinaemic vasculitis","volume":"70","author":"De Vita","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1373\/clinchem.2007.090134","article-title":"A\u00a0critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins","volume":"54","author":"Vermeersch","year":"2008","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib51","first-page":"77","article-title":"Serum complement pattern in essential mixed cryoglobulinaemia","volume":"32","author":"Tarantino","year":"1978","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib52","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","article-title":"Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia","volume":"50","author":"Wener","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2014.09.008_bib53","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.1995.01690220030006","article-title":"Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus","volume":"131","author":"Dupin","year":"1995","journal-title":"Arch Dermatol"},{"issue":"Pt 3","key":"10.1016\/j.rdc.2014.09.008_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/brain\/111.3.541","article-title":"Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases","volume":"111","author":"Nemni","year":"1988","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib55","first-page":"121","article-title":"Sural nerve bioptic findings in essential cryoglobulinemic patients with and without peripheral neuropathy","volume":"11","author":"Tredici","year":"1992","journal-title":"Clin Neuropathol"},{"issue":"10","key":"10.1016\/j.rdc.2014.09.008_bib56","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/jnnp.53.10.886","article-title":"A\u00a0clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy","volume":"53","author":"Cavaletti","year":"1990","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"197","key":"10.1016\/j.rdc.2014.09.008_bib57","first-page":"1","article-title":"Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients","volume":"50","author":"Tarantino","year":"1981","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005792-200209000-00005","article-title":"The clinical and morphologic spectrum of renal cryoglobulinemia","volume":"81","author":"Beddhu","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib59","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/ajkd.1998.v31.pm9506691","article-title":"Thrombotic microangiopathy associated with cryoglobulinemic membranoproliferative glomerulonephritis and hepatitis C","volume":"31","author":"Herzenberg","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ajcp\/79.2.147","article-title":"The clinicopathologic features of cryoglobulinemic nephropathy","volume":"79","author":"Ben-Bassat","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rdc.2014.09.008_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keu271","article-title":"Validation of the classification criteria for cryoglobulinaemic vasculitis","author":"Quartuccio","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10157-013-0854-0","article-title":"ACR\/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)","volume":"17","author":"Craven","year":"2013","journal-title":"Clin Exp Nephrol"},{"issue":"Suppl 13","key":"10.1016\/j.rdc.2014.09.008_bib63","first-page":"S123","article-title":"Classification of the cryoglobulinemic syndrome","volume":"13","author":"Invernizzi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.09.008_bib64","first-page":"1098","article-title":"Cryoglobulinemic disease","volume":"27","author":"Retamozo","year":"2013","journal-title":"Oncology (Williston Park)"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11926-014-0420-0","article-title":"Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach","volume":"16","author":"Perez-Alamino","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.rdc.2014.09.008_bib66","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12185-013-1323-y","article-title":"Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review","volume":"97","author":"Besada","year":"2013","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.rdc.2014.09.008_bib67","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/10428194.2012.671481","article-title":"Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature","volume":"54","author":"Payet","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/keh503","article-title":"Rituximab inefficiency during type I cryoglobulinaemia","volume":"44","author":"Nehme-Schuster","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ncpneph0823","article-title":"Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis","volume":"4","author":"Pandrangi","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/RHU.0b013e3182155e8d","article-title":"Type 1 cryoglobulinemia: response to thalidomide and lenalidomide","volume":"17","author":"Calabrese","year":"2011","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib71","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/RHU.0b013e3181d0bfef","article-title":"Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma","volume":"16","author":"Lin","year":"2010","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.09.008_bib72","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus\u2013associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib73","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2012-202770","article-title":"Peg-IFNalpha\/ribavirin\/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24","volume":"73","author":"Saadoun","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib75","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.34326","article-title":"Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy","volume":"64","author":"St Clair","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature","volume":"11","author":"Ferri","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib78","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.rdc.2014.09.008_bib79","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib80","first-page":"403","article-title":"Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment","volume":"23","author":"Lidove","year":"1999","journal-title":"Gastroenterol Clin Biol"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib81","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A\u00a0randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib82","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A\u00a0randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2014.09.008_bib83","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis","volume":"60","author":"Sene","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2014.09.008_bib85","first-page":"650","article-title":"Effect of plasmapheresis (PP), corticosteroids and cyclophosphamide in essential mixed polyclonal cryoglobulinaemia associated with glomerulonephritis","volume":"17","author":"Houwert","year":"1980","journal-title":"Proc Eur Dial Transplant Assoc"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib86","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1053\/j.gastro.2010.02.004","article-title":"Glucocorticosteroids increase cell entry by hepatitis C virus","volume":"138","author":"Ciesek","year":"2010","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.rdc.2014.09.008_bib87","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2169\/internalmedicine.45.1816","article-title":"Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations","volume":"45","author":"Cakir","year":"2006","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.rdc.2014.09.008_bib88","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7326\/0003-4819-149-12-200812160-00019","article-title":"Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis","volume":"149","author":"Enomoto","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.rdc.2014.09.008_bib89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00004836-200305000-00020","article-title":"Successful treatment of hepatitis B-associated vasculitis with lamivudine","volume":"36","author":"Stecevic","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2012.10.014","article-title":"Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia","volume":"56","author":"Boglione","year":"2013","journal-title":"J\u00a0Clin Virol"},{"issue":"10","key":"10.1016\/j.rdc.2014.09.008_bib91","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/jmv.20695","article-title":"Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients","volume":"78","author":"Kosmas","year":"2006","journal-title":"J\u00a0Med Virol"},{"issue":"16","key":"10.1016\/j.rdc.2014.09.008_bib92","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.2013.281115","article-title":"FDA: increased HBV reactivation risk with ofatumumab or rituximab","volume":"310","author":"Mitka","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.rdc.2014.09.008_bib93","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.20318","article-title":"Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"25","key":"10.1016\/j.rdc.2014.09.008_bib94","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","article-title":"Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey","volume":"119","author":"Terrier","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib95","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","article-title":"Plasma exchange for treating cryoglobulinemia: a descriptive analysis","volume":"42","author":"Rockx","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1681\/ASN.V73367","article-title":"Therapeutic plasma exchange in renal diseases","volume":"7","author":"Madore","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1526-0968.2003.00036.x","article-title":"Indications of plasma exchanges for systemic vasculitides","volume":"7","author":"Guillevin","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"2","key":"10.1016\/j.rdc.2014.09.008_bib98","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ndt\/14.2.281","article-title":"Glomerulonephritis in mixed cryoglobulinaemia: what treatment?","volume":"14","author":"Campise","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J\u00a0Clin Apher"},{"issue":"1","key":"10.1016\/j.rdc.2014.09.008_bib100","first-page":"69","article-title":"Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenstrom and multiple myeloma: influence on blood rheology and the microcirculation","volume":"119","author":"Reinhart","year":"1992","journal-title":"J\u00a0Lab Clin Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.09.008_bib101","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1167\/iovs.07-1254","article-title":"Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia","volume":"49","author":"Menke","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"10.1016\/j.rdc.2014.09.008_bib102","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N\u00a0Engl J Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:31Z","timestamp":1760181211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X14000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0889857X14000970"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2014.09.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cold Hard Facts of Cryoglobulinemia","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2014.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}